Literature DB >> 26086136

How many memories does it take to make an SLE flare?

David M Tarlinton1, Kenneth G C Smith2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26086136     DOI： 10.1038/ni.3209

Source DB:  PubMed          Journal:  Nat Immunol        ISSN： 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  10 in total

1.  Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.

Authors:  William Stohl; Falk Hiepe; Kevin M Latinis; Mathew Thomas; Morton A Scheinberg; Ann Clarke; Cynthia Aranow; Frank R Wellborne; Carlos Abud-Mendoza; Douglas R Hough; Lilia Pineda; Thi-Sau Migone; Z John Zhong; William W Freimuth; W Winn Chatham
Journal:  Arthritis Rheum       Date:  2012-07

2.  Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls.

Authors:  A M Jacobi; D M Goldenberg; F Hiepe; A Radbruch; G R Burmester; T Dörner
Journal:  Ann Rheum Dis       Date:  2007-08-02       Impact factor: 19.103

3.  Diversity among memory B cells: origin, consequences, and utility.

Authors:  David Tarlinton; Kim Good-Jacobson
Journal:  Science       Date:  2013-09-13       Impact factor: 47.728

Review 4.  A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.

Authors:  Gal Yaniv; Gilad Twig; Dana Ben-Ami Shor; Ariel Furer; Yaniv Sherer; Oshry Mozes; Orna Komisar; Einat Slonimsky; Eyal Klang; Eyal Lotan; Mike Welt; Ibrahim Marai; Avi Shina; Howard Amital; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2015-01       Impact factor: 9.754

Review 5.  Sequencing the functional antibody repertoire--diagnostic and therapeutic discovery.

Authors:  William H Robinson
Journal:  Nat Rev Rheumatol       Date:  2014-12-23       Impact factor: 20.543

6.  Barcode-enabled sequencing of plasmablast antibody repertoires in rheumatoid arthritis.

Authors:  Yann-Chong Tan; Sarah Kongpachith; Lisa K Blum; Chia-Hsin Ju; Lauren J Lahey; Daniel R Lu; Xiaoyong Cai; Catriona A Wagner; Tamsin M Lindstrom; Jeremy Sokolove; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-10       Impact factor: 10.995

7.  Identification of the 9G4 idiotope in systemic lupus erythematosus.

Authors:  D Isenberg; M Spellerberg; W Williams; M Griffiths; F Stevenson
Journal:  Br J Rheumatol       Date:  1993-10

8.  Correlation of 9G4 idiotope with disease activity in patients with systemic lupus erythematosus.

Authors:  D A Isenberg; C McClure; V Farewell; M Spellerberg; W Williams; G Cambridge; F Stevenson
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

Review 9.  Sites and stages of autoreactive B cell activation and regulation.

Authors:  Mark J Shlomchik
Journal:  Immunity       Date:  2008-01       Impact factor: 31.745

10.  Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus.

Authors:  Christopher M Tipton; Christopher F Fucile; Jaime Darce; Asiya Chida; Travis Ichikawa; Ivan Gregoretti; Sandra Schieferl; Jennifer Hom; Scott Jenks; Ron J Feldman; Ramit Mehr; Chungwen Wei; F Eun-Hyung Lee; Wan Cheung Cheung; Alexander F Rosenberg; Iñaki Sanz
Journal:  Nat Immunol       Date:  2015-05-25       Impact factor: 25.606
  10 in total
  1 in total

1.  Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.

Authors:  Diana Klose; Mira Woitok; Judith Niesen; Roger R Beerli; Ulf Grawunder; Rainer Fischer; Stefan Barth; Rolf Fendel; Thomas Nachreiner
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.